Literature DB >> 8256201

In vitro antibody response of human lymphocytes to the Haemophilus influenzae type b capsular polysaccharide.

C C Peeters1, A M Tenbergen-Meekes, J T Poolman, B J Zegers, G T Rijkers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8256201     DOI： 10.1007/bf00201105

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  33 in total

1.  In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.

Authors:  J L Munoz; R A Insel
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

2.  Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.

Authors:  C Lue; A Tarkowski; J Mestecky
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.

Authors:  J D Sedgwick; P G Holt
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

4.  Specific in vitro antibody responses by human blood lymphocytes: apparent nonresponsiveness of PBL is due to a lack of recirculating memory B cells.

Authors:  R E Callard; G W McCaughan; J Babbage; R L Souhami
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.

Authors:  D M Granoff; G A Weinberg; P G Shackelford
Journal:  Pediatr Res       Date:  1988-08       Impact factor: 3.756

7.  Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.

Authors:  J Eskola; H Käyhty; H Peltola; V Karanko; P H Mäkelä; J Samuelson; L K Gordon
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

Review 8.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.

Authors:  A C Allison; N E Byars
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

9.  Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

Authors:  R Schneerson; J B Robbins; J C Parke; C Bell; J J Schlesselman; A Sutton; Z Wang; G Schiffman; A Karpas; J Shiloach
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

Review 10.  Prospects for overcoming maturational and genetic barriers to the human antibody response to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  P Anderson; R A Insel
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641
View more
  1 in total

1.  Regulatory T cells in the antibody response to Haemophilus influenzae type b polysaccharide.

Authors:  M A Breukels; G T Rijkers; M M Voorhorst-Ogink; B J Zegers
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.